tiprankstipranks
Trending News
More News >
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market

Prelude Therapeutics (PRLD) Cash flow

Compare
169 Followers

Prelude Therapeutics Cash Flow

PRLD's free cash flow for Q3 2025 was $-19.11M. For the 2025 fiscal year, PRLD's free cash flow was decreased by $6.92M and operating cash flow was $-19.11M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -102.89M$ -107.06M$ -83.73M$ -83.53M$ -46.18M
Investing Cash Flow
$ 90.19M$ -34.65M$ 81.69M$ -263.80M$ -621.00K
Financing Cash Flow
$ -120.00K$ 136.40M$ 815.00K$ 164.90M$ 246.23M
End Cash Position
$ 16.52M$ 29.34M$ 34.65M$ 35.87M$ 218.31M
Free Cash Flow
$ -103.65M$ -110.58M$ -86.75M$ -85.85M$ -46.80M
Currency in USD

Prelude Therapeutics Cash Flow